DK0877612T3 - Anvendelse af piperazinderivater til behandling af cognitive forstyrrelser - Google Patents
Anvendelse af piperazinderivater til behandling af cognitive forstyrrelserInfo
- Publication number
- DK0877612T3 DK0877612T3 DK93923615T DK93923615T DK0877612T3 DK 0877612 T3 DK0877612 T3 DK 0877612T3 DK 93923615 T DK93923615 T DK 93923615T DK 93923615 T DK93923615 T DK 93923615T DK 0877612 T3 DK0877612 T3 DK 0877612T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- cognitive disorders
- pct
- piperazine derivatives
- date
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929223153A GB9223153D0 (en) | 1992-11-05 | 1992-11-05 | Piperazine derivatives |
| PCT/GB1993/002197 WO1994009780A1 (en) | 1992-11-05 | 1993-10-25 | Use of piperazine derivatives for the treatment of cognitive disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0877612T3 true DK0877612T3 (da) | 2000-10-09 |
Family
ID=10724559
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK93923615T DK0877612T3 (da) | 1992-11-05 | 1993-10-25 | Anvendelse af piperazinderivater til behandling af cognitive forstyrrelser |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5827847A (es) |
| EP (1) | EP0877612B1 (es) |
| JP (1) | JP3238153B2 (es) |
| AT (1) | ATE195422T1 (es) |
| AU (1) | AU682155B2 (es) |
| CA (1) | CA2148593C (es) |
| DE (1) | DE69329252T2 (es) |
| DK (1) | DK0877612T3 (es) |
| ES (1) | ES2149216T3 (es) |
| GB (1) | GB9223153D0 (es) |
| GR (1) | GR3034400T3 (es) |
| HU (1) | HUT72049A (es) |
| LV (1) | LV12734B (es) |
| MX (1) | MX9306879A (es) |
| PT (1) | PT877612E (es) |
| TW (1) | TW252043B (es) |
| WO (1) | WO1994009780A1 (es) |
| ZA (1) | ZA937827B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0710481A1 (en) * | 1994-11-02 | 1996-05-08 | Duphar International Research B.V | Use of flesinoxan for cognition enhancement |
| US6271234B1 (en) * | 1997-08-01 | 2001-08-07 | Recordati S.A., Chemical And Pharmaceutical Company | 1,4-disubstituted piperazines |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2355502A1 (fr) * | 1976-06-23 | 1978-01-20 | Roussel Uclaf | Application a titre de medicaments d'un derive de la piperazine et de ses sels |
| US4423049A (en) * | 1981-12-28 | 1983-12-27 | Mead Johnson & Company | 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines |
| GB2222768B (en) * | 1988-06-17 | 1992-01-22 | Nat Res Dev | Analgesic compounds and compositions |
| GB8909209D0 (en) * | 1989-04-22 | 1989-06-07 | Wyeth John & Brother Ltd | Piperazine derivatives |
| US4902687A (en) * | 1989-03-27 | 1990-02-20 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| NZ233398A (en) * | 1989-04-22 | 1991-12-23 | American Home Prod | Aryl- or heteroaryl-substituted piperazine derivatives and pharmaceutical compositions |
| ATE179973T1 (de) * | 1989-04-22 | 1999-05-15 | Wyeth John & Brother Ltd | Piperazin-derivate |
| EP0398413A1 (en) * | 1989-05-16 | 1990-11-22 | Duphar International Research B.V | "3,4-dehydropiperidine derivatives having psychotropic activity |
| DK0510068T3 (da) * | 1990-01-11 | 1999-10-25 | Upjohn Co | Nye 6,7,8,9-tetrahydro-3H-benz(e)indol-heterocycler med virkning på centralnervesystemet |
| GB9022820D0 (en) * | 1990-10-19 | 1990-12-05 | Wyeth John & Brother Ltd | Piperazine derivatives |
| DE4039631A1 (de) * | 1990-12-12 | 1992-06-17 | Troponwerke Gmbh & Co Kg | Neuroprotektive kombination |
| IL101722A (en) * | 1991-05-02 | 1996-05-14 | Wyeth John & Brother Ltd | History of piperazine, their preparation and pharmaceutical preparations containing them |
| DE4135551A1 (de) * | 1991-08-31 | 1993-03-04 | Schering Ag | Verwendung von antagonisten oder partiellen agonisten am 5-ht1a-rezeptor zur behandlung und praevention von kognitiven stoerungen |
-
1992
- 1992-11-05 GB GB929223153A patent/GB9223153D0/en active Pending
-
1993
- 1993-10-21 ZA ZA937827A patent/ZA937827B/xx unknown
- 1993-10-25 JP JP51081394A patent/JP3238153B2/ja not_active Expired - Fee Related
- 1993-10-25 PT PT93923615T patent/PT877612E/pt unknown
- 1993-10-25 EP EP93923615A patent/EP0877612B1/en not_active Expired - Lifetime
- 1993-10-25 DK DK93923615T patent/DK0877612T3/da active
- 1993-10-25 AT AT93923615T patent/ATE195422T1/de not_active IP Right Cessation
- 1993-10-25 AU AU53421/94A patent/AU682155B2/en not_active Ceased
- 1993-10-25 US US08/428,093 patent/US5827847A/en not_active Expired - Fee Related
- 1993-10-25 ES ES93923615T patent/ES2149216T3/es not_active Expired - Lifetime
- 1993-10-25 CA CA002148593A patent/CA2148593C/en not_active Expired - Fee Related
- 1993-10-25 HU HU9501290A patent/HUT72049A/hu unknown
- 1993-10-25 WO PCT/GB1993/002197 patent/WO1994009780A1/en active IP Right Grant
- 1993-10-25 DE DE69329252T patent/DE69329252T2/de not_active Expired - Fee Related
- 1993-10-26 TW TW082108882A patent/TW252043B/zh active
- 1993-11-04 MX MX9306879A patent/MX9306879A/es not_active IP Right Cessation
-
2000
- 2000-09-13 GR GR20000402090T patent/GR3034400T3/el not_active IP Right Cessation
-
2001
- 2001-07-04 LV LVP-01-102A patent/LV12734B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2148593A1 (en) | 1994-05-11 |
| JPH08502743A (ja) | 1996-03-26 |
| DE69329252D1 (de) | 2000-09-21 |
| GB9223153D0 (en) | 1992-12-16 |
| EP0877612A1 (en) | 1998-11-18 |
| ATE195422T1 (de) | 2000-09-15 |
| HUT72049A (en) | 1996-03-28 |
| DE69329252T2 (de) | 2001-03-29 |
| GR3034400T3 (en) | 2000-12-29 |
| AU5342194A (en) | 1994-05-24 |
| AU682155B2 (en) | 1997-09-25 |
| WO1994009780A1 (en) | 1994-05-11 |
| HU9501290D0 (en) | 1995-06-28 |
| US5827847A (en) | 1998-10-27 |
| ZA937827B (en) | 1995-04-21 |
| JP3238153B2 (ja) | 2001-12-10 |
| TW252043B (es) | 1995-07-21 |
| LV12734B (en) | 2002-01-20 |
| LV12734A (en) | 2001-10-20 |
| ES2149216T3 (es) | 2000-11-01 |
| MX9306879A (es) | 1995-01-31 |
| EP0877612B1 (en) | 2000-08-16 |
| CA2148593C (en) | 2005-12-06 |
| PT877612E (pt) | 2000-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE19680619D2 (de) | Verwendung von Adamantan-Derivaten zur Behandlung von Erkrankungen des Innenohrs | |
| ES2141174T3 (es) | 4-arilmetiloximetil piperidinas como antagonistas de taquiquinina. | |
| DK0652871T3 (da) | Absorberende artikel med fastgøringssystem, der tilvejebringer dynamisk tilpasning af elasticeret linning | |
| DE59409312D1 (de) | Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten | |
| DE69433984D1 (de) | Arylpiperazinderivate von indol als liganden der rezeptoren 5 ht1-like, 5 ht1b und 5 ht1d | |
| DE69424009D1 (de) | Verwendung von (S)-(-)-alpha-ethyl-2-oxo-1-pyrrolidinacetamid zur Herstellung eines Medikaments zur Behandlung von Angst | |
| ES2123756T3 (es) | Derivados de piperazina. | |
| DK0632805T3 (da) | Melaminderivater til anvendelse i behandlingen af cancer | |
| NO308532B1 (no) | Farmasøytiske piperazinforbindelser | |
| DK0877612T3 (da) | Anvendelse af piperazinderivater til behandling af cognitive forstyrrelser | |
| TW281673B (es) | ||
| DK1068184T3 (da) | N-aryloxyethylaminderivater til behandling af despression | |
| DE69431471T2 (de) | Amidderivate als 5-HT1A-Liganden | |
| ATE219083T1 (de) | 4-oxo-und 4h-imidazo(5,1-c)(1,4)benzoxazine nützlich als benzodiazepinrezeptor-bindemittel. | |
| SE9603284D0 (sv) | New compounds | |
| DE59309469D1 (de) | Triazolochinazoline zur behandlung zentralnervöser erkrankungen |